Hepatosplenic T-cell lymphoma: a rare but challenging entity.
Pro B, Allen P, Behdad A.
Blood. 2020 Oct 29;136(18):2018-2026. doi: 10.1182/blood.2019004118.
Hepatosplenic T-cell lymphoma: treatment challenges.
Bron D, De Leval L, Michiels S, Wittnebel S; EuroBloodNet for rare diseases.
Curr Opin Oncol. 2021 Sep 1;33(5):406-411. doi: 10.1097/CCO.0000000000000775.
Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.
Yabe M, Miranda RN, Medeiros LJ.
Hum Pathol. 2018 Apr;74:5-16. doi: 10.1016/j.humpath.2018.01.005. Epub 2018 Jan 11.
Hepatosplenic T-cell lymphoma in children and adolescents.
Schwartz LF, Devine KJ, Xavier AC.
Blood Adv. 2025 Apr 22;9(8):1847-1858. doi: 10.1182/bloodadvances.2025015857.
Extranodal T- and NK-cell lymphomas.
de Leval L, Feldman AL, Pileri S, Nakamura S, Gaulard P.
Virchows Arch. 2023 Jan;482(1):245-264. doi: 10.1007/s00428-022-03434-0. Epub 2022 Nov 7.
Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum.
Chowdhury Z, Khonglah Y, Raphael V, Kalita P, Das U.
Int J Hematol Oncol Stem Cell Res. 2022 Jan 1;16(1):66-73. doi: 10.18502/ijhoscr.v16i1.8444.
Hepatosplenic gamma-delta T-Cell Lymphoma: Who Is on Your Speed Dial?
Krishnan M, Lunning M.
J Oncol Pract. 2019 Jun;15(6):307-312. doi: 10.1200/JOP.18.00594.
Hepatosplenic gamma-delta T-cell lymphoma.
Ferreri AJ, Govi S, Pileri SA.
Crit Rev Oncol Hematol. 2012 Aug;83(2):283-92. doi: 10.1016/j.critrevonc.2011.10.001. Epub 2011 Nov 1.
Hepatosplenic T-Cell Lymphomas.
Gowda L, Foss F.
Cancer Treat Res. 2019;176:185-193. doi: 10.1007/978-3-319-99716-2_9.
Hepatosplenic T-cell lymphoma diagnosed using flow cytometry. A single-center study of 12 cases from North India.
Rahman K, Gupta T, Gupta R, Singh L, Chandra D, Sarkar MK, Singh MK, Kumar S, Nityanand S.
J Cancer Res Ther. 2022 Jul-Sep;18(4):1093-1097. doi: 10.4103/jcrt.JCRT_877_19.
